Russell Investments Group, Ltd.

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1692234 Seattle, WA

Position in MRVI

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$392,640

-$38,766 QoQ

Shares Held

138,743

+4.5% QoQ

Ownership

0.054%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 97.02759778871727.ToString("F0")% Shared 0.ToString("F0")% None 2.972402211282731.ToString("F0")%

Healthcare · as of Mar 31, 2026

Russell Investments Group, Ltd. holds $1,224,022,354 across 265 Biotechnology names. MRVI ranks #133 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	228,086	$176,228,356
2	VRTX	Vertex Pharmaceuticals Inc / Ma	367,691	$164,188,731
3	RPRX	Royalty Pharma plc	1,397,958	$67,060,041
4	INCY	Incyte Corp	638,242	$60,071,331
5	ALNY	Alnylam Pharmaceuticals, Inc.	147,533	$48,814,236
6	MRNA	Moderna, Inc.	710,640	$36,100,509
7	BMRN	Biomarin Pharmaceutical Inc	606,224	$34,245,589
8	INSM	INSMED Inc	169,162	$27,661,365

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$392,640	138,743	+4.5%	Shares	Defined	2026-05-08
2025-12-31	$431,406	132,741	+18.2%	Shares	Defined	2026-02-17
2025-09-30	$322,317	112,307	+178.4%	Shares	Defined	2025-11-13
2025-06-30	$97,232	40,346	-0.7%	Shares	Other	2025-08-13
2025-03-31	$89,835	40,650	+2477.7%	Shares	Defined	2025-05-13
2024-06-30	$11,291	1,577	-88.0%	Shares	Defined	2024-08-08
2024-03-31	$114,278	13,181	-88.3%	Shares	Defined	2024-05-08
2023-12-31	$737,502	112,596	+62802.8%	Shares	Defined	2024-02-05
2023-09-30	$1,790	179	+588.5%	Shares	Defined	2023-11-13
2023-06-30	$323	26	-99.1%	Shares	Defined	2023-08-10
2023-03-31	$39,592	2,826	-88.1%	Shares	Defined	2023-05-09
2022-12-31	$340,362	23,785	—	Shares	Sole	2023-02-08
No filing history on record for this holder in this stock.